Table 1.

Sequences of experimental primers.

Target Gene	Accession Number	Forward (5′–3′)	Reverse (5′–3′)
CD40	NM_011611	ACCAGCAAGGATTGCGAGGCAT	GGATGACAGACGGTATCAGTGG
CD80	NM_009855	CCTCAAGTTTCCATGTCCAAGGC	GAGGAGAGTTGTAACGGCAAGG
CD86	NM_019388	ACGTATTGGAAGGAGATTACAGCT	TCTGTCAGCGTTACTATCCCGC
MHC-II	NM_207105	GTGTGCAGACACAACTACGAGG	CTGTCACTGAGCAGACCAGAGT
CAT	NM_009804	GCTCTCACATGGCTGCGAAGG	TCCTCAGGCTCGGCTTCACG
SOD	NM_011434	AACCAGTTGTGTTGTCAGGAC	CCACCATGTTTCTTAGAGTGAGG
GSR	NM_010344	CGGCGTGGAGGTGTTGAAGTTC	TGGTCGTGGTGGGCTTCCTAC
Nrf2	NM_010902	AAGCACAGCCAGCACATTCTCC	TGACCAGGACTCACGGGAACTTC
Keap1	NM_001110305	ATCCAGAGAGGAATGAGTGGCG	TCAACTGGTCCTGCCCATCGTA
NQO1	NM_008706	GCGAGAAGAGCCCTGATTGTACTG	AGCCTCTACAGCAGCCTCCTTC
HO-1	NM_010442	ACCGCCTTCCTGCTCAACATTG	CTCTGACGAAGTGACGCCATCTG
IKBKB	NM_010546	GCAGACTGACATTGTGGACCTG	ATCTCCTGGCTGTCACCTTCTG
IκB-Alpha	NM_010907	GCCAGGAATTGCTGAGGCACTT	GTCTGCGTCAAGACTGCTACAC
NF-κB p65	NM_009045	TCCTGTTCGAGTCTCCATGCAG	GGTCTCATAGGTCCTTTTGCGC
GAPDH	NM_008084	CATCACTGCCACCCAGAAGACTG	ATGCCAGTGAGCTTCCCGTTCAG